Gritstone bio, Inc. (GRTS) Tops Q3 EPS by 1c

Gritstone bio, Inc. (NASDAQ: GRTS) reported Q3 EPS of ($0.33), $0.01 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $1.57 million versus the consensus estimate of $1.89 million.

For earnings history and earnings-related data on Gritstone bio, Inc. (GRTS) click here.

You May Also Be Interested In

• Etsy upgraded to buy at BofA on durable growth, buyback potential
• Ross Stores (ROST) Tops Q2 EPS by 72c, Beats on Revenue
• Twin Disc (TWIN) Tops Q4 EPS by 16c